affiliation not provided to SSRN
metastatic colorectal cancer, primary tumor sidedness, metastatic pattern, liver-limited disease, predictive biomarker, biomarker combination, comprehensive statisticalmodelling, FOLFIRI, cetuximab, bevacizumab